Archived Events – 2011
December 13, 2011: Dutch Life Sciences and Health Conference
Details: Representatives from Cato Research will attend the Dutch Life Sciences and Health Conference in Utrecht, the Netherlands. Over the past couple of years, the conference has been attended by more than 300 representatives from the Dutch and international life sciences industries. Consequently the conference is the most efficient way to meet and connect with management representatives of early stage, emerging and large (bio) pharmaceutical, medical device and health care companies. Furthermore, representatives from research institutes and the financial sector, such as venture capitalists, business angels and corporate venture capitalists, will also be present.
For more information and to register: Dutch Life Sciences and Health Conference
December 10-13, 2011: 2011 American Society of Hematology Annual Meeting
Details: Representatives from Cato Research will attend the 2011 American Society of Hematology Annual Meeting and Exposition in San Diego, California. This 53rd annual meeting offers valuable benefits for all attendees, including: the opportunity to grow professionally. Hematology is a constantly changing field, and ASH's Education and Scientific Program can help you stay up-to-date on the latest research, therapies, and tools you need to succeed. The meeting also offers many networking events that will allow you to connect with colleagues and interact with leaders in the field to learn and share your ideas.
For more information and to register: American Society for Hematology
December 6, 2011 – 5-8:30PM: Cato Research and Cato BioVentures Host Wine Tasting and Reception
Details: Cato Research and Cato BioVentures will be hosting a Wine Tasting and Reception at the Cato Research Durham office on December 6, 2011 from 5-8:30 PM. Please join us for an array of delicious appetizers, as well as wines from Dr. Cato's personal collection. We look forward to seeing you there!
To register: Wine Tasting and Reception Registration
Directions: Cato Research Durham Office
November 16-17, 2011: DIA Electronic Submissions 2011
Details: Representatives from Cato Research will attend the DIA Electronic Submissions 2011 in San Diego, California
As eCTD has matured and been implemented in many global markets, it has also raised expectations and scrutiny of data standards, caused an increase in the amount of regional requirements, and created the need for additional validators. This year's conference will feature collaborative working sessions on specific topics and ICH modules that will give you the opportunity to interact and share the challenges you face and discuss how to overcome them.
For more information and to register: DIA Electronic Submissions 2011
November 15, 2011, 1-2 PM EST: Free Educational Webinar
Presentation Details: Modern Drug Development - Optimal Clinical Study Designs and International Regulatory Strategies
In today's competitive climate, it is essential to optimize clinical trials during early development, to best predict success in pivotal trials and position clinical outcomes for licensing and marketing. Please join us at a joint webinar between the Netherlands Centre for Human Drug Development (CHDR) and Cato Research that addresses current challenges and provides clinical and regulatory strategies to the most expeditious and cost-effective path towards clinical proof of concept and approval.
Our experts for the webinar are: Professor Adam Cohen, CEO of CHDR and Dr. Kimberley Cummings, Senior Director, Regulatory Affairs at Cato Research.
For more information and to register: Free Educational Webinar
November 2-3, 2011: 13th Annual Southeast BIO Investor Forum
Details: Representatives from Cato Research will attend the 13th Annual Southeast BIO Investor Forum in Durham, North Carolina
The Southeast BIO Investor Forum is the Southeast region's premier life sciences venture capital conference, connecting emerging life science companies with potential investors in a forum that provides meaningful networking opportunities.
For more information and to register: SEBIO Investor Forum
October 25-27, 2011: SAS Premier Business Leadership Series
Details: Representatives from Cato Research will attend the SAS Premier Business Leadership Series in Orlando, Florida
Business leaders have always been expected to make smart decisions to keep the organization profitable and competitive, but that is no longer enough. Today's executive must be an inspiring force who leads the charge to transform the organization's culture to one of innovation and optimization.
For more information and to register: SAS Premier Business Leadership Series
October 25-26, 2011: 10th Annual BIO Investor Forum
Details: Representatives from Cato BioVentures will attend the 10th Annual BIO Investor Forum in San Francisco, California.
The 10th Annual BIO Investor Forum is an international investor conference focused on private and emerging public biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
For more information and to register: BIO Investor Forum
October 19, 2011 – 5-8PM: Cato Research and Cato BioVentures Host Wine Tasting and Reception
Details: Cato Research and Cato BioVentures will be hosting a Wine Tasting and Reception at the Cato Research Washington office in Rockville, Maryland on October 19, 2011 from 5-8 PM. Please join us for an array of delicious appetizers, as well as wines from Dr. Cato's personal collection. We look forward to seeing you there!
To register: Wine Tasting and Reception Registration
Directions: Cato Research Washington Office
October 12, 2011: NCBIO Annual Meeting
Details: Representatives from Cato Research will attend the 2011 NCBIO Annual Meeting in Research Triangle Park, North Carolina
Dr. Andrew von Eschenbach, former Commissioner of the Food and Drug Administration will be a Keynote Speaker at the NCBIO Annual Meeting at the North Carolina Biotechnology Center. Dr. von Eschenbach will discuss medical innovation policy and offer unique insights stemming from his years of experience at the FDA, the National Cancer Institute and the American Cancer Society.
For more information and to register: NCBIO
September 28-29, 2011: 3rd Annual Outsourcing in Clinical Trials New England
Details: Representatives from Cato Research will attend the 3rd Annual Outsourcing in Clinical Trials New England in Boston, Massachusetts
The Outsourcing in Clinical Trials series primarily serves to give rise to new, successful business relationships. As the industry is under increasing pressure to make clinical trials more efficient while keeping costs under control, creating solid partnerships and developing effective outsourcing strategies are pivotal to beating competition and key to successful and continuous drug development.
For more information and to register: Outsourcing in Clinical Trials New England
September 22-23, 2011: Cancer Advances Presenting at NCI Conference
Details: Representatives from Cancer Advances will present a poster at the Cancer Immunology and Immunotherapy: Building on Success conference in Bethesda, Maryland
On September 22 and 23, the Center of Excellence in Immunology at the Center for Cancer Research, National Cancer Institute (NCI) will host the Cancer Immunology and Immunotherapy: Building on Success conference at the National Institute of Health in Bethesda, Maryland. The conference will host leaders in translational and clinical research to discuss the most cutting edge immunological approaches and advances in preventing and treating cancer. Representatives from Cancer Advances have been selected to give a poster presentation on its novel, anti-gastrin antibody (AGA) named Polyclonal Antibody Stimulator (PAS) in the treatment of advanced pancreatic cancer.
For more information about Cancer Advances: Cancer Advances
For more information about the conference: NCI Cancer Immunology and Immunotherapy
September 11-14, 2011: 2011 SCDM Annual Conference
Details: Representatives from Cato Research will attend the 2011 Society for Clinical Data Management Annual Conference in Baltimore, MD
The SCDM Annual Conference is the world's largest education event for clinical data managers and related professionals, attracting approximately 650 attendees from across North America and around the world.
For more information and to register: 2011 SCDM Annual Conference
September 7, 2011 – 5:30-9 PM: Cato Research Hosts Wine Tasting and Reception
Details: Cato Research will be hosting a Wine Tasting and Reception on the 21st floor of the historic Custom House in Boston, Massachusetts on September 7, 2011 from 5:30-9 PM. Please join senior management from Cato Research for an array of delicious appetizers, as well as wines from Dr. Cato's personal collection. We look forward to seeing you there!
To register: Wine Tasting and Reception Registration
Directions: Custom House, Boston, Massachusetts
September 7-9, 2011: BioPharm America 2011
Details: Representatives from Cato Research will attend BioPharm America 2011 in Boston, Massachusetts
BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. In addition to productive partnering, BioPharm America offers high level workshops, panels, company presentations, and a lively exhibition.
For more information and to register: BioPharm America 2011
August 1, 2011 – 6-7 PM: SoCRA North Carolina East Chapter Meeting at Cato Research
Presentation Details: Prospects for personalized treatment approaches in oncology product development
The August 2011 meeting of the Society of Clinical Research Associates North Carolina Chapter will be held on Monday August 1, 2011, at Cato Research from 6:00 to 7:00 PM. This month's meeting will feature Marga Oortgiesen, Ph.D., R.A.C., C.C.R.P.,VP Drug Development, Cato Research. Dr. Oortgiesen will be speaking on new developments in cancer research.
For more information: SoCRA Chapter News
July 13, 2011, 12-1 PM EST: Free Educational Webinar
Presentation Details: Reasons to Switch to eCTD
Cato Research's Evan Richardson is presenting at this free educational webinar hosted by GlobalSubmit. The eCTD format continues to grow as the standard for regulatory submissions worldwide, and the FDA has made it very clear that it prefers to receive submissions in eCTD format. However, when many smaller biotech and pharma companies reach the IND or NDA/BLA stages, they still often consider paper submissions as a viable option.
Featured topics include:
- Pros & cons for making the switch from paper to eCTD submissions
- Why eCTD submissions are the best choice for any sponsor
- Real-world case studies of the benefits of eCTD submissions
For more information and to register: GlobalSubmit Webinar
July 13, 2011 - 4:30 – 8:30 PM: Cato Research Hosts Wine Tasting and Reception
Details: Cato Research and Cato BioVentures will be hosting a Wine Tasting and Reception at Cato Research's San Franscisco, CA office on Wednesday, 13 July 2011 from 4:30 to 8:30 PM. Please join our San Francisco team for an array of delicious appetizers, as well as wines from Dr. Cato's personal collection. We look forward to seeing you there!
To register: Wine Tasting and Reception Registration
Directions: Directions to Wine Tasting and Reception
June 27-30, 2011: BIO 2011
Details: Representatives from Cato Research and Cato BioVentures will attend the 2011 BIO International Convention in Washington DC
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
For more information and to register: BIO 2011
June 15, 2011 - 10 AM EST: Free Educational Webinar
Presentation Details: New Rules in FDA Safety Reporting: Are You Prepared?
Please join us as we focus on the FDA's new rule, "Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans," which became effective on 28 March 2011. This rule affects safety reporting of adverse events and, as always, there is much to be interpreted. What is the FDA really saying? What does this mean to you and the sponsors you serve? How might the new rule affect your company's current processes? We will highlight the changes and describe concerns raised by many in the field.
Our experts for the webinar are Jackson Snyder, Clinical Research Physician and Angela Overton, Associate Director of Pharmacovigilance of Cato Research.
For more information and to register: Cato Research Events
June 8, 2011 - 4:30 – 8:30 PM: Cato Research Hosts Wine Tasting and Reception
Details: Cato Research and Cato BioVentures will be hosting a Wine Tasting and Reception at Cato Research's San Diego, CA office on Wednesday, 8 June 2011 from 4:30 to 8:30 PM. Please join our San Diego team for an array of delicious appetizers, as well as wines from Dr. Cato's personal collection. We look forward to seeing you there!
To register: Wine Tasting and Reception Registration
Directions: Directions to Wine Tasting and Reception
June 3-7, 2011: ASCO 2011 Annual Meeting
Presentation Details: Representatives from Cato Research will attend the American Society of Clinical Oncology 2011 Annual Meeting in Chicago, Illinois
The 2011 Annual Meeting will center on a theme of "Patients, Pathways, Progress." The Annual Meeting offers a wide variety of educational opportunities for oncology professionals to learn about the latest strategies for prevention, screening, diagnosis, treatment, translational research, and current controversies in the field.
For more information and to register: ASCO 2011 Annual Meeting
May 31 - June 1, 2011: BioFinance 2011
Presentation Details: Representatives from Cato Research will attend BioFinance 2011 in Toronto, Ontario, Canada
BioFinance is the leading investor conference in Canada for the life sciences industry. This event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector. Presenting companies span a range of industries including: biologics, medical devices, drug delivery, vaccines, diagnostics, bio-energy, green technologies, bio materials, industrial biotech, and research services.
For more information and to register: BioFinance 2011
May 2-4, 2011: Biomarker World Congress 2011
Presentation Details: Representatives from Cato Research will attend the Biomarker World Congress 2011 in Philadelphia, Pennsylvania
Cambridge Healthtech Institute's Seventh Annual Biomarker World Congress 2011 is the leading annual meeting dedicated to biomarker research and implementation.
For more information and to register: Biomarker World Congress 2011
April 30 - May 1, 2011: ACRP Global Conference and Exhibition
Presentation Details: Representatives from Cato Research will attend ACRP 2011 Global Conference and Exhibition in Seattle, Washington
The Association of Clinical Research Professionals is the primary resource for clinical research professionals in the pharmaceutical, biotechnology and medical device industries, and those in hospital, academic medical centers and physician office settings. The 2011 Global Conference and Exhibition is an opportunity to join colleagues at the premier event for the clinical research profession featuring premium educational content and important networking opportunities.
For more information: ACRP 2011
April 26, 2011, 2:00 PM EST: Free Educational Webinar
Presentation Details: Clinical Trial Management and SharePoint
Join BioClinica and Cato Research for a free educational webinar. Presented by Jeremiah Rehm, Clinical Solutions Specialist at BioClinica, and Darcy Vieira, Senior Clinical Research Manager at Cato Research.
SharePoint's flexibility and manageability are changing the clinical application landscape. Jeremiah Rehm, Clinical Solutions Specialist at BioClinica, will discuss the tremendous opportunities that SharePoint offers for clinical operations and for the IT staff that supports them. He will illustrate how to maximize SharePoint's capabilities by freeing clinical data from application silos while meeting regulatory requirements for clinical trials.
For more information and to register: Cato Events
April 20-21, 2011: BayBio: Annual Conference - Powering Global Innovation
Presentation Details: Representatives from Cato Research will attend BayBio 2011 in Burlingame, California
With Northern California regarded as a global innovation engine, the BayBio2011 Annual Conference will explore themes and topics that focus on fostering global collaborations in research, development and commercialization.
For more information and to register: BayBio 2011
April 2-6, 2011: AACR 102nd Annual Meeting
Presentation Details: Representatives from Cato Research will attend the 102nd Annual Meeting of the American Association for Cancer Research in Orlando, Florida
Once again, AACR will host and organize an exciting program on the best and latest in cancer research, in which a wide swath of the cancer research community will participate, to advance the cause of treating and preventing cancer. The program will not only reflect the AACR's strengths in basic, translational, and clinical research, but also emphasize the productive interfaces emerging between these once-separated disciplines. The program will capture the advances on all these fronts, with a range of speakers and participants who are leaders in research: cancer mechanisms, systems approaches to cancer biology, diagnostics and therapeutics, translation of advances to the clinic, and cutting-edge science in the prevention and early interception of cancer.
For more information and to register: AACR 102nd Annual Meeting 2011
March 28-29, 2011: Clinical Research in Canada: Global Competitiveness
Presentation Details: Representatives from Cato Research will attend Clinical Research in Canada in Montreal, Quebec
The Canadian Institute brings together key industry leaders and stakeholders to discuss Canada's place in the clinical research global landscape. This important event will give you the critical information you need to develop proactive strategies to build Canada's competitive advantage. This interactive program includes key policy makers from both the federal and provincial government who will share their vision and their plans to lead Canada through these challenging times. You will also hear the latest best practices and innovations that are coming down the pipeline from big pharma, biotech, CROs, research hospitals and universities.
For more information: Clinical Research in Canada
March 14-16, 2011: BIO-Europe Spring 2011
Presentation Details: Representatives from Cato BioVentures will attend the BIO-Europe Spring 2011 conference in Milan, Italy
Where the global biotech industry comes to partner. BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group's sophisticated, web-based partnering system partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
For more information: BIO-Europe Spring 2011
March 9-13, 2011: NCCN Annual Conference
Presentation Details: Cato Research and Cato BioVentures to Attend NCCN Annual Conference: Clinical Practice Guidelines and Quality Cancer Care
The NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ attracts more than 1,700 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™), the data upon which the NCCN Guidelines™ are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas. The NCCN Annual Conference also includes case study discussion forums with experts from NCCN Member Institutions and roundtable discussions featuring the foremost professionals from the academic, patient advocacy, government, payor, industry, and business realms of cancer care.
For more information and to register: NCCN Annual Conference
March 1, 2011, 3:00 PM EDT: Free Educational Webinar
Presentation Details: FDA Review Process
Join GlobalSubmit and Cato Research for a free educational webinar. Presented by Jason Rock, Chief Technology Officer at GlobalSubmit and Evan Richardson, Associate Director Regulatory Operations at Cato Research.
The purpose of this educational webinar is to inform you of the various steps and stages that a drug application goes through in order to be approved by the FDA and marketed in the United States. The webinar will review the FDA's workflow, the challenges they face in the electronic submission process and common errors in a submission. In addition, the webinar will share eCTD best practices, while underlining the importance of using validation software when submitting your eCTD to ensure that your submission will not be rejected due to technical error. GlobalSubmit Inc., a leading developer of eCTD review and validation software for FDA use, is aware that technical issues can prevent your INDs, NDAs, etc. from being approved by the FDA. Our close relationship with the FDA has provided us the experience and expertise to help.
Mr. Rock is a technology visionary and leader within the eCTD community at large. He has over 10 years of experience working with global life sciences companies and regulatory agencies to promote the adoption of the eCTD through the development of advanced applications. In his role as CTO, Mr. Rock provides strong leadership for the strategic and technical direction of GlobalSubmit's product architecture and development. He is a frequent guest speaker at numerous industry forums such as DIA, RAPS and others. Mr. Rock chairs the HL7 Regulated Product (RPS) initiative and works closely with the U.S. FDA for their deployment of GlobalSubmit applications as well as various technology programs involving regulatory submissions.For more information and to register: Cato Research Events
February 21-22, 2011: CHI Early Oncology Partnering Forum
Presentation Details: Cato BioVentures Presents Personalized Oncology Product Development: Immune Response Gastrin-17 Maximizes Clinical Benefit in Cancer Patients
This session is designed to provide a series of perspectives from companies that represent potential partners for the early stage companies showcased in the rest of the program. Each Perspective Presenter will address some of the criteria and factors that they take into consideration when considering earlier stage collaborations.
Cancer Advances is a biotechnology company focused on impacting the progression of gastrointestinal cancers by enhancing the adaptive immune system to inhibit the hormone gastrin. The lead compound, Polyclonal Antibody Stimulator (PAS) is designed to elicit antibodies against human gastrin-17 and has been tested in multiple clinical trials including trials in gastric, pancreatic, and colorectal cancer. Overall, across all indications, patients who generate an antibody response to PAS show improved survival over those that do not develop a response to PAS.For more information and to register: Early Oncology Partnering Forum
February 21-22, 2011, CED Annual Biotech Life Science Conference
Presentation Details: Representatives from Cato Research and Cato BioVentures will attend CED's Annual Biotech Life Science Conference in Raleigh NC.
CED's annual Biotech/Life Science Conference unites the Southeast life science community to celebrate one of the industry's most dynamic regions. This two-day conference includes world-class speakers, a variety of panels on industry topics and trends, and networking opportunities with life science leaders. Join industry executives, including the region's most innovative entrepreneurs, major pharmaceutical companies, research leaders, policy makers and nationally prominent investors at the Southeast's premier life science event.
For more information: CED Biotech Life Science Conference
January 31, 2011, 3:00 PM EDT: Free Educational Webinar
Presentation Details: Planning Investigator Meetings
Free educational webinar. Presented by Andrew Daleus, BS, RAC, Sr. Project Manager at Cato Research, and Kim Howard, CMP, Vice President TMP Services
Join Cato Research as we host a free webinar to discuss our process for selecting and partnering with investigator meeting planning vendors. We'll be joined by Kim Howard, Vice President of TMP Meeting Services, who will share information on what makes the best meeting planning partner as well as new investigator meeting regulations in the healthcare and lifesciences industry.
For more information and to register: Cato Research Events
Presentation: Planning Investigator Meetings
January 19, 2011, NCBIO Emerging Companies Forum
Presentation Details: Cato Research will be sponsoring and attending the NCBIO Emerging Companies Forum
With North Carolina State government facing a $3.4 billion budget shortfall, key programs supporting North Carolina's emerging life science companies may be targeted for cuts. Programs potentially affected include funding for SBIR/STTR grants; funding for the North Carolina Biotechnology Center, including the Center's loan and grant programs; incentives for companies to expand; and extension of the Qualified Business Venture Tax Credit. Tax reform issues may also be debated. Hear from NCBIO President Sam Taylor and help assure your company's priorities are reflected in NCBIO's 2011 legislative agenda.
For more informations: NCBIO Emerging Companies Forum
January 10-13, 2011, 29th Annual J.P. Morgan Healthcare Conference
Presentation Details: Representatives from Cato Research and Cato BioVentures will attend the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
J.P. Morgan conferences bring together industry leaders, financial sponsors and investors to explore market and sector trends. This event is the premier conference of its kind, bringing together established industry leaders, emerging fast-growth companies, innovative technology creators and globally minded service providers. This year more than 300 comapanies are expected to attend, both public and private, to deliver presentations to more than 4000 investors.
For more information about J.P. Morgan conferences: J.P. Morgan Conferences
January 10-12, 2011, Biotech Showcase 2011
Presentation Details: Representatives from Cato BioVentures will attend the Biotech Showcase in San Francisco, CA.
Biotech Showcase™ provides private and public life science companies the opportunity to present to an audience of investors and business development executives during the course of the world's largest annual healthcare investor conference. In its third year, Biotech Showcase moves to Parc 55 Wyndham San Francisco – Union Square and will expand to three full days. The program will include lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics, as well as presentations from both private and public companies.
For more information: Biotech Showcase 2011